NCT06862869 2026-04-06
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
Recruiting
Hoffmann-La Roche
Seoul National University Bundang Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS